AAAAAA
Results:
1-9
|
Results: 9
Authors:
Lyass, O
Hubert, A
Gabizon, AA
Citation: O. Lyass et al., Phase I study of doxil-cisplatin combination chemotherapy in patients withadvanced malignancies, CLIN CANC R, 7(10), 2001, pp. 3040-3046
Authors:
Hubert, A
Lyass, O
Pode, D
Gabizon, A
Citation: A. Hubert et al., Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer, ANTI-CANC D, 11(2), 2000, pp. 123-127
Authors:
Safra, T
Muggia, F
Jeffers, S
Tsao-Wei, DD
Groshen, S
Lyass, O
Henderson, R
Berry, G
Gabizon, A
Citation: T. Safra et al., Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m(2), ANN ONCOL, 11(8), 2000, pp. 1029-1033
Authors:
Barak, V
Nisman, B
Hubert, A
Lyass, O
Kaduri, L
Peretz, T
Citation: V. Barak et al., Prognostic efficacy of TPS in breast cancer, J TUMOR M, 15(3), 2000, pp. 171-176
Authors:
Lyass, O
Uziely, B
Ben-Yosef, R
Tzemach, D
Heshing, NI
Lotem, M
Brufman, G
Gabizon, A
Citation: O. Lyass et al., Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma, CANCER, 89(5), 2000, pp. 1037-1047
Authors:
Lotem, M
Hubert, A
Lyass, O
Goldenhersh, MA
Ingber, A
Peretz, T
Gabizon, A
Citation: M. Lotem et al., Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin, ARCH DERMAT, 136(12), 2000, pp. 1475-1480
Authors:
Nisman, B
Amir, G
Lafair, J
Heching, N
Lyass, O
Peretz, T
Barak, V
Citation: B. Nisman et al., Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer, ANTICANC R, 19(4C), 1999, pp. 3549-3552
Authors:
Zelefsky, MJ
Crean, D
Mageras, GS
Lyass, O
Happersett, L
Ling, CC
Leibel, SA
Fuks, Z
Bull, S
Kooy, HM
van Herk, M
Kutcher, GJ
Citation: Mj. Zelefsky et al., Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy, RADIOTH ONC, 50(2), 1999, pp. 225-234
Authors:
Symon, Z
Peyser, A
Tzemach, D
Lyass, O
Sucher, E
Shezen, E
Gabizon, A
Citation: Z. Symon et al., Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes, CANCER, 86(1), 1999, pp. 72-78
Risultati:
1-9
|